Prostate medications that increase availability of adenosine triphosphate are associated with a reduced risk for dementia with Lewy bodies.
Certain medications that are used to treat benign prostatic hyperplasia are associated with a reduced risk for dementia with Lewy bodies , the second most common neurodegenerative type of dementia after Alzheimer's disease.
."If we can determine that an existing drug can offer protection against this debilitating disease, that has the potential to greatly reduce its effects."Increasing ATP Neuroprotective? There have been case reports of PD being linked to mutations affecting PGK1. Researchers speculate that increased ATP availability in neurons resulting from the activation of PKG1 allows cells to better adapt to aging and synuclein aggregation.
After following claimants for an average of 3 years, 195 participants developed DLB who were taking Tz, Dz, or Az, a rate of 5.21 cases per 10,000 people per year.
Alzheimer Disease Lewy Body Dementia Dementia With Lewy Bodies Benign Prostatic Hyperplasia BPH Benign Prostatic Hypertrophy BPH - Benign Prostatic Hyperplasia Nodular Hyperplasia BEP - Benign Enlargement Of The Prostate Dementia Prostatic Prostate Carcinoma Malignant Prostate Neoplasm Prostate Cancer Cancer Of The Prostate Parkinson's Disease Parkinson Disease
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Certain Prostate Meds Might Help Prevent DementiaProstate medications might help reduce the risk of a specific type of dementia, a new study suggests.
Read more »
Commonly Used Meds Tied to Lower Risk for Brain Aneurysm RuptureCommonly prescribed drugs are associated with lower risk for aneurysmal subarachnoid hemorrhage. Conversely, four other meds were tied to an increased risk for the condition.
Read more »
Most Outpatient Mental Health Clinics Don't Offer Opioid Addiction MedsOnly a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds.
Read more »
Study Shows 58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight LossI'm an independent healthcare analyst with more than 25 years of experience analyzing, publishing and presenting/educating on healthcare policy and pharmaceuticals. I have 114 publications in peer-reviewed journals, in addition to more than 450 articles in periodicals and newspapers. I have also presented my work at numerous conferences.
Read more »
Hey Teens, No Obesity Meds for You, Experts SayExperts with the U.S. Preventive Services Task Force say not enough data has been collected to know whether newer obesity medications for teens are safe.
Read more »
It's Safe to Take GLP-1 Weight Loss Meds Before Surgery: StudyDespite recent concerns that taking Ozempic, Wegovy or other GLP-1 medications might be unsafe before a surgery, a new review has uncovered no such danger.
Read more »